Searched for
NATCO PHARMA FY26
ITC's business with BAT grows 10% to Rs 1,587 crore in FY26, but dividend payout falls 9%ITC's business with major shareholder British American Tobacco (BAT) saw a 10% expansion in sales to Rs 1,587 crore in FY26, though dividen...- Two British American Tobacco-linked entities receive Rs 3,896 crore ITC dividend in FY26British American Tobacco's Indian entities received ₹3,895.74 crore in dividends from ITC in FY26, a slight decrease from the previous year...
- Petroleum vulnerability rising, India must build crude buffers and cut import dependence, EY cautionsIndia faces mounting vulnerability due to its soaring dependence on imported crude oil, now exceeding 90%. A recent EY report urges augment...
- India's higher nominal GDP growth may help contain fiscal pressures despite global risks: EYIndia's fiscal deficit is expected to remain under control in FY27, thanks to robust nominal GDP growth driven by higher inflation, accordi...
- NSE IPO to value exchange at Rs 5 lakh crore? 2 scenarios every investor should watchNSE's proposed IPO could value the exchange at around Rs 5 lakh crore, making it one of India's most valuable listed financial institutions...
- ITC Chairman Sanjiv Puri's pay packet shrinks 6.8% to Rs 23.9 crore in FY26In FY26, Sanjiv Puri, the Chairman and Managing Director of ITC, saw his total compensation decline by 6.8% to Rs 23.91 crore. This reducti...
- ITC CMD total remuneration slips 6.8% to Rs 23.91 crore in FY26ITC Chairman and Managing Director Sanjiv Puri's total pay saw a 6.8% dip to Rs 23.91 crore in FY26, primarily due to lower performance bon...
- Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...
- On This Day in History, June 26: UN Charter signed, Indira Gandhi declares Emergency, Harry Potter debuts, Corvette day, Sher Shah Suri wins against Mughals and moreOn This Day in History, June 26 saw the signing of the United Nations Charter, Richard III's rise to the English throne, India's declaratio...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- EY, KPMG, Deloitte among top 10 auditors by number of companies audited in FY26India’s audit market in FY26 remained dominated by large firms, with EY, KPMG and Deloitte leading by audit volume and market capitalisatio...
- Affordable housing finance firms likely to regain growth in FY27, but macro risks loom: KotakAffordable housing finance companies are poised for a growth rebound from FY27, according to Kotak Institutional Securities. After a subdue...
- Tech Mahindra CEO Mohit Joshi’s FY26 pay climbs 12% to Rs 67.5 croreTech Mahindra CEO Mohit Joshi's pay surged 11.7% to Rs 67.5 crore in FY26, surpassing peers at Wipro and TCS. This reflects the company's a...
- Infosys’ Salil Parekh topped IT CEO pay in FY26; here’s what the big chiefs madeInfosys CEO Salil Parekh led the pack among top Indian IT executives in FY26, earning Rs 82.6 crore. Tech Mahindra's Mohit Joshi followed w...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- L’Oréal acquires Innovist in big D2C deal; Dhan’s FY26 profit shrinksL’Oréal has bought Innovist to claw back momentum in India’s hyper-competitive beauty market. This and more in today’s ETtech Top 5.
- Dhan parent Raise Securities posts Rs 905 crore revenue, profit down 20% in FY26The company had reported net operating income of Rs 795 crore and a profit after tax of Rs 408 crore in FY25. The rating agency attributed ...
Load More
